Connecticut Oncology Group

Middletown, Connecticut 06457

0 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Colorectal Neoplasms, NSCLC, Non-small Cell Lung Cancer, Prostatic Neoplasms, Rectal Neoplasms

Studies at this site

• Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer. — Completed
• Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC) — Completed
• An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry) — Completed
• Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer — Completed